Boston Scientific: FDA approval for Farawave NAV Ablation Catheter for treatment of paroxysmal atrial fibrillation and for new Faraview Software

Boston Scientific Corporation announced it has received FDA approval for the navigation-enabled Farawave NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) and FDA 510(k) clearance for the new Faraview Software, which will combine to provide visualization for cardiac ablation procedures with the Farapulse Pulsed Field Ablation (PFA) System